Vikas Gupta, CEO and Chief Investment Strategist at OmniScience Capital, said he would avoid technology stocks due to uncertain fundamental prospects amid the impact of AI. He also believes the sector is overvalued given the outlook. He remains cautious on pharma as well, citing overvaluation.
Daily Voice: Prolonged low-intensity war likely after US elections? Investment Strategist bets on safe havens; shuns IT, pharma
Recent Posts
- Rising crude oil prices, hike in lending rates affect sentiment for small-caps
- Nifty can hit 42,800 level in next five years: Report
Archive
- October 2026
- September 2026
- August 2026
- July 2026
- June 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- October 2022
- July 2022
- June 2021
- March 2021
- October 2020